Mesoblast (MESO) EBT (2014 - 2023)

Mesoblast has reported EBT for 10 years, with the latest figure at -$22.0 million in Q2 2023.

• Quarterly EBT fell 2.1% year-over-year to -$22.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$82.1 million (up 10.36% YoY) and the FY2025 annual result came in at -$101.8 million, down 15.5% from the prior year.
• EBT fell to -$22.0 million in Q2 2023 per MESO's latest filing, from -$18.6 million in the prior quarter.
• Over five years, EBT peaked at -$7.4 million in Q3 2019 and troughed at -$35.9 million in Q2 2020.
• A 5-year average of -$22.9 million and a median of -$23.3 million in 2019 frame the typical range for EBT.
• The sharpest annual moves came in 2019 and 2020: EBT surged 63.3% in 2019, then slumped 240.8% in 2020.
• Over 5 years, EBT stood at -$26.9 million in 2019, then increased by 4.6% to -$25.6 million in 2020, then declined by 1.59% to -$26.0 million in 2021, then gained by 5.64% to -$24.6 million in 2022, then increased by 10.58% to -$22.0 million in 2023.
• According to Business Quant data, EBT over the past three periods registered -$22.0 million, -$18.6 million, and -$24.6 million for Q2 2023, Q1 2023, and Q4 2022 respectively.